Neith (Taiwan) Performance
| 6236 Stock | TWD 25.55 0.05 0.20% |
The company secures a Beta (Market Risk) of -0.59, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Neith are expected to decrease at a much lower rate. During the bear market, Neith is likely to outperform the market. Neith right now secures a risk of 3.89%. Please verify Neith standard deviation, information ratio, and the relationship between the coefficient of variation and variance , to decide if Neith will be following its current price movements.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Neith has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Neith is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Quick Ratio | 0.37 | |
| Fifty Two Week Low | 6.61 | |
| Fifty Two Week High | 25.50 |
Neith |
Neith Relative Risk vs. Return Landscape
If you would invest 2,645 in Neith on October 26, 2025 and sell it today you would lose (90.00) from holding Neith or give up 3.4% of portfolio value over 90 days. Neith is generating 0.0308% of daily returns and assumes 3.8919% volatility on return distribution over the 90 days horizon. Simply put, 34% of stocks are less volatile than Neith, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Neith Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neith's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Neith, and traders can use it to determine the average amount a Neith's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Estimated Market Risk
| 3.89 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Neith is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neith by adding Neith to a well-diversified portfolio.
Neith Fundamentals Growth
Neith Stock prices reflect investors' perceptions of the future prospects and financial health of Neith, and Neith fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neith Stock performance.
| Return On Equity | -62.52 | |||
| Return On Asset | -17.19 | |||
| Profit Margin | (74.50) % | |||
| Operating Margin | (66.83) % | |||
| Current Valuation | 356.02 M | |||
| Shares Outstanding | 31.65 M | |||
| Price To Book | 4.33 X | |||
| Price To Sales | 3.18 X | |||
| Revenue | 91.12 M | |||
| EBITDA | (53.54 M) | |||
| Cash And Equivalents | 25.61 M | |||
| Cash Per Share | 0.81 X | |||
| Total Debt | 46.31 M | |||
| Debt To Equity | 61.90 % | |||
| Book Value Per Share | 2.27 X | |||
| Cash Flow From Operations | (38.99 M) | |||
| Earnings Per Share | (2.14) X | |||
About Neith Performance
Evaluating Neith's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Neith has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Neith has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Come True Biomedical Inc. engages in the biotechnology, medical cosmetics, and preventive medicine businesses. Come True Biomedical Inc. was founded in 1997 and is headquartered in Taipei City, Taiwan. COME TRUE operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.Things to note about Neith performance evaluation
Checking the ongoing alerts about Neith for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neith help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Neith had very high historical volatility over the last 90 days | |
| The company has NT$46.31 Million in debt which may indicate that it relies heavily on debt financing | |
| Neith has accumulated 46.31 M in total debt with debt to equity ratio (D/E) of 61.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Neith has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Neith until it has trouble settling it off, either with new capital or with free cash flow. So, Neith's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Neith sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Neith to invest in growth at high rates of return. When we think about Neith's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 91.12 M. Net Loss for the year was (67.89 M) with profit before overhead, payroll, taxes, and interest of 80.37 M. | |
| Neith has accumulated about 25.61 M in cash with (38.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. |
- Analyzing Neith's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neith's stock is overvalued or undervalued compared to its peers.
- Examining Neith's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neith's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neith's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neith's stock. These opinions can provide insight into Neith's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Neith Stock Analysis
When running Neith's price analysis, check to measure Neith's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neith is operating at the current time. Most of Neith's value examination focuses on studying past and present price action to predict the probability of Neith's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neith's price. Additionally, you may evaluate how the addition of Neith to your portfolios can decrease your overall portfolio volatility.